samareh panjeshahi

Mrs. samareh panjeshahi


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2023 in Human Genetics
Verified
Journal Article
Closed access
PDF file
SPsamareh panjeshahi
samareh panjeshahi
PKParvaneh Karimzadeh
Parvaneh Karimzadeh
AMAbolfazl Movafagh
Abolfazl Movafagh
FAFarzad Ahmadabadi
Farzad Ahmadabadi
ERElham Rahimian
Elham Rahimian
MMMohammad Miryounesi
Mohammad Miryounesi

10 August 2023 in Journal of Nephropathology
Verified
Journal Article
Open access
PPPaniz Pourpashang
Paniz Pourpashang
NENasrin Esfandiar
Nasrin Esfandiar
SPsamareh panjeshahi
samareh panjeshahi
SSSamin Sharafian
Samin Sharafian
SMSeyed Hamidreza Mirbehbahani
Seyed Hamidreza Mirbehbahani
Schimke immuno-osseous dysplasia (SIOD) is a rare disease diagnosed by skeletal malformations, steroid-resistant nephrotic syndrome (SRNs), and T-cell immunodeficiency. Proteinuria with focal segmental glomerulosclerosis (FSGS) is the most common renal pathologic finding in SIOD. In this case report, we present an 8-year-old boy with generalized edema, kyphosis, and nephrotic syndrome who was eventually diagnosed with SIOD.

1 February 2023 in Research Square
Verified
Preprint
Open access
PDF file
SPsamareh panjeshahi
samareh panjeshahi
PKParvaneh Karimzadeh
Parvaneh Karimzadeh
AMAbolfazl Movafagh
Abolfazl Movafagh
FAFarzad Ahmadabadi
Farzad Ahmadabadi
ERElham Rahimian
Elham Rahimian
MMMohammad Miryounesi
Mohammad Miryounesi
Neuronal ceroid lipofuscinoses (NCLs) are neurodegenerative lysosomal storage diseases witch considered among the most frequent cause of dementia in childhood worldwide This study aimed to identify the gene variants, molecular etiologies, and clinical features in 23 unrelated Iranian families with NCL. In total, 29 patients with Neuronal ceroid lipofuscinoses (NCLs), diagnosed based on clinical manifestations, MRI neuroimaging, and electroencephalography (EEG), were recruited for this study. through whole exome sequencing(WES), functional prediction, Sanger sequencing, and segregation analysis, we found that 12 patients (41.3%) with mutations in the CLN6 gene, 7 patients (24%) with the TPP1(CLN2) gene variants, and 4 patients (13.7%) with mutations in the MFSD8(CLN7) gene. Also, mutations in each of the CLN3 and CLN5 genes were detected in 2 cases and mutations of each PPT1(CLN1) and CLN8 gene were observed in only 1 separate patient. We identified 18 different mutations, 11 (61%) of which are novel, never have been reported before, and the others have been previously described. The gene variants identified in this study expand the number of published clinical cases and the variant frequency spectrum of the Neuronal ceroid lipofuscinoses (NCLs) genes; moreover, the identification of these variants supplies foundational clues for future NCL diagnosis and therapy.

1 July 2024 in Basic and Clinical Neuroscience Journal
Verified
Journal Article
Open access
PDF file
SASahar Alijanpour
Sahar Alijanpour
SGSoudeh Ghafouri-Fard
Soudeh Ghafouri-Fard
STSeyed Hassan Tonekaboni
Seyed Hassan Tonekaboni
PKParvaneh Karimzadeh
Parvaneh Karimzadeh
FAFarzad Ahmadabadi
Farzad Ahmadabadi
MMMohammad Miryounesi
Mohammad Miryounesi
Introduction: Developmental and epileptic encephalopathy 9 (DEE9) is caused by pathogenic variants in the PCDH19 gene. The clinical features include early-onset seizures that are often provoked by fever and display clustered seizures, mild to profound intellectual disability, autistic traits, and behavioral disturbances. DEE9 is characterized by an unusual X-linked pattern where ...